Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 152 No. 2324 (2022)

“Shaping the new freedom”: A reflexive thematic analysis on patients’ post cure needs after years of living with hepatitis C

  • Helen  Guggisberg
  • Dunja Nicca
  • Anton Kohler
  • Philip Bruggmann
  • Patrizia Künzler-Heule
DOI
https://doi.org/10.4414/SMW.2022.w30177
Cite this as:
Swiss Med Wkly. 2022;152:w30177
Published
13.06.2022

Summary

BACKGROUND: Direct-acting antivirals present a treatment opportunity that provides high rates of sustained viral response even for people who have lived for years with hepatitis C virus (HCV) infection. While it is known that liver-related morbidity and mortality can be decreased and many symptoms reversed, this population's need for post-treatment professional support has not been extensively assessed. Therefore, our study aimed to describe the experiences of patients cured of chronic HCV infection and explore the meaning of these experiences regarding specific follow-up care needs within the context of the Swiss health system.

METHODS: For this qualitative study, we applied a reflexive thematic analysis approach with a social constructivist orientation. Twelve participants shared their experiences of being cured and their needs regarding follow-up care. Subsequently, the data were analysed in an iterative process based on Braun and Clarke's six phases of analysis.

RESULTS: In the overarching theme, participants summarised their new situation with the statement, “being cured feels like being released from a cage”. They experienced striking health improvements with overwhelmingly positive influences on their everyday lives. This experience was characterised for all participants by important changes on three levels. We categorised these in three sub-themes: a) “the ball and chain have been lightened”: this sub-theme illustrates the reduction of social limitations and emotional stress; b) “the gnawing at the liver has let up”: this signifies relief from physical symptoms and strongly improved well-being. And under the third sub-theme, “shaping the new freedom”, the participants described their new situation as a sometimes-stressful challenge because they had to reorient their self-management. They shared their concerns regarding the ongoing stigma of HCV infection, feeling insecure in their own health after being cured, and learning how to use their heightened sense of confidence and openness to enact behavioural changes that would improve their health-related lifestyles.

CONCLUSION: The findings of this study provide insights into treatment experiences of patients cured of chronic HCV infection and the need for follow-up care even after successful virus eradication. The results can sensitise healthcare professionals to patients’ post-cure challenges and guide their care interventions. Some of these challenges, such as dealing with stigma, can be addressed during treatment; other needs, like providing motivation to engage in healthy behaviour, may warrant targeted follow-up.

References

  1. World Health Organization (WHO). Hepatitis C 2021 [cited 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c
  2. Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet. 2016 Sep;388(10049):1081–8. https://doi.org/10.1016/S0140-6736(16)30579-7
  3. Bihl F, Bruggmann P, Castro Batänjer E, Dufour J-F, Lavanchy D, Müllhaupt B, et al. HCV disease burden and population segments in Switzerland. Liver International. 2021;n/a(n/a).
  4. Roelens M, Bertisch B, Moradpour D, Cerny A, Semmo N, Schmid P, et al. All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS). Open Forum Infect Dis. 2020;7(8):ofaa308-ofaa.
  5. Pawlotsky JM, Negro F, Aghemo A, Berenguer M, Dalgard O, Dusheiko G, et al.; European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; Clinical Practice Guidelines Panel: Chair; EASL Governing Board representative; Panel members. EASL recommendations on treatment of hepatitis C: final update of the series☆. J Hepatol. 2020 Nov;73(5):1170–218. https://doi.org/10.1016/j.jhep.2020.08.018
  6. Carrat F, Fontaine H, Dorival C, Simony M, Diallo A, Hezode C, et al.; French ANRS CO22 Hepather cohort. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. Lancet. 2019 Apr;393(10179):1453–64. https://doi.org/10.1016/S0140-6736(18)32111-1
  7. Bruggmann P, Hepatitis C. Eine Erfolgsgeschichte. Primary and Hospital Care: Allgemeine Innere Medizin. 2018;16:282–5.
  8. Moradpour D, Müllhaupt B. [Hepatitis C: current therapy]. Rev Med Suisse. 2015 Apr;11(471):902–6.
  9. Conrad S, Garrett LE, Cooksley WG, Dunne MP, MacDonald GA. Living with chronic hepatitis C means ‘you just haven’t got a normal life any more’. Chronic Illn. 2006 Jun;2(2):121–31.
  10. Glacken M, Coates V, Kernohan G, Hegarty J. The experience of fatigue for people living with hepatitis C. J Clin Nurs. 2003 Mar;12(2):244–52. https://doi.org/10.1046/j.1365-2702.2003.00709.x
  11. Glacken M, Kernohan G, Coates V. Diagnosed with Hepatitis C: a descriptive exploratory study. Int J Nurs Stud. 2001 Feb;38(1):107–16. https://doi.org/10.1016/S0020-7489(00)00046-8
  12. Fry M, Bates G. The tasks of self-managing hepatitis C: the significance of disclosure. Psychol Health. 2012;27(4):460–74. https://doi.org/10.1080/08870446.2011.592982
  13. Janke EA, McGraw S, Garcia-Tsao G, Fraenkel L. Psychosocial issues in hepatitis C: a qualitative analysis. Psychosomatics. 2008 Nov-Dec;49(6):494–501. https://doi.org/10.1176/appi.psy.49.6.494
  14. Butt G, Paterson BL, McGuinness LK. Living with the stigma of hepatitis C. West J Nurs Res. 2008 Mar;30(2):204–21. https://doi.org/10.1177/0193945907302771
  15. Moore GA, Hawley DA, Bradley P. Hepatitis C: experiencing stigma. Gastroenterol Nurs. 2009 Mar-Apr;32(2):94–104. https://doi.org/10.1097/SGA.0b013e31819de48b
  16. Juanbeltz R, Martínez-Baz I, San Miguel R, Goñi-Esarte S, Cabasés JM, Castilla J. Impact of successful treatment with direct-acting antiviral agents on health-related quality of life in chronic hepatitis C patients. PLoS One. 2018 Oct;13(10):e0205277. https://doi.org/10.1371/journal.pone.0205277
  17. Evon DM, Sarkar S, Amador J, Lok AS, Sterling RK, Stewart PW, et al. Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: the PROP UP study. J Hepatol. 2019 Sep;71(3):486–97. https://doi.org/10.1016/j.jhep.2019.04.016
  18. Goutzamanis S, Spelman T, Harney B, Dietze P, Stoove M, Higgs P, et al. Patient-reported outcomes of the Treatment and Prevention Study: A real-world community-based trial of direct-acting antivirals for hepatitis C among people who inject drugs. J Viral Hepat. 2021 Jul;28(7):1068–77. https://doi.org/10.1111/jvh.13516
  19. Fagundes RN, Ferreira LEVVdC, Pace FHdL. Health-related quality of life and fatigue in patients with chronic hepatitis C with therapy with direct-acting antivirals agents interferon-free. PloS one. 2020;15(8):e0237005-e.
  20. Madden A, Hopwood M, Neale J, Treloar C. Beyond cure: patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia. Harm Reduct J. 2018 Aug;15(1):42. https://doi.org/10.1186/s12954-018-0248-4
  21. Torrens M, Soyemi T, Bowman D, Schatz E. Beyond clinical outcomes: the social and healthcare system implications of hepatitis C treatment. BMC Infect Dis. 2020 Sep;20(1):702. https://doi.org/10.1186/s12879-020-05426-4
  22. Pourmarzi D, Smirnov A, Hall L, FitzGerald G, Rahman T. ‘I’m over the moon!’: patient-perceived outcomes of hepatitis C treatment. Aust J Prim Health. 2020 Aug;26(4):319–24. https://doi.org/10.1071/PY20013
  23. Richmond JA, Ellard J, Wallace J, Thorpe R, Higgs P, Hellard M, et al. Achieving a hepatitis C cure: a qualitative exploration of the experiences and meanings of achieving a hepatitis C cure using the direct acting antivirals in Australia. Hepatol Med Policy. 2018 Aug;3(1):8. https://doi.org/10.1186/s41124-018-0036-5
  24. Moradpour D, Fehr J, Semela D, Rauch A, Müllhaupt B. Treatment of Chronic Hepatitis C- January 2021 Update Expert Opinition Statement by SASL, SSG and SSI. Swiss Association for the Liver. 2021.
  25. Jacobs LA, Shulman LN. Follow-up care of cancer survivors: challenges and solutions. Lancet Oncol. 2017 Jan;18(1):e19–29. https://doi.org/10.1016/S1470-2045(16)30386-2
  26. Braun V, Clarke V. Reflecting on reflexive thematic analysis. Qual Res Sport Exerc Health. 2019;11(4):589–97. https://doi.org/10.1080/2159676X.2019.1628806
  27. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013 Nov;310(20):2191–4. https://doi.org/10.1001/jama.2013.281053
  28. Creswell JW, Poth CN. Qualitative Inquiry and research design: choosing among five approaches Thousand Oaks. Sage. 2017.
  29. Swiss Hepatitis Strategy. Swiss Hepatitis Strategy 2014- 2030. 2019.
  30. INVOLVE. Briefing notes for researchers: public involvement in NHS, public health and social care research 2012 [Available from: http://www.invo.org.uk/wp-content/uploads/2014/11/9938_INVOLVE_Briefing_Notes_WEB.pdf
  31. Shippee ND, Domecq Garces JP, Prutsky Lopez GJ, Wang Z, Elraiyah TA, Nabhan M, et al. Patient and service user engagement in research: a systematic review and synthesized framework. Health Expect. 2015 Oct;18(5):1151–66. https://doi.org/10.1111/hex.12090
  32. Braun V, Clarke V. Evaluating and reviewing TA research: A checklist for editors and reviewers.2017. Available from: https://cdn.auckland.ac.nz/assets/psych/about/our-research/documents/TA%20website%20update%2010.8.17%20review%20checklist.pdf
  33. Stagg HR, Surey J, Francis M, MacLellan J, Foster GR, Charlett A, et al. Improving engagement with healthcare in hepatitis C: a randomised controlled trial of a peer support intervention. BMC Med. 2019 Apr;17(1):71. https://doi.org/10.1186/s12916-019-1300-2
  34. Bobzin C, Bsiger C, Bruggmann P, Cerny A, Christinet M, Keiser O, et al. Empfehlungen für die Nachsorge von Patientinnen/Patienten mit ausgeheilter Hepatitis C. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum. 2021.
  35. Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002 Nov;288(19):2469–75. https://doi.org/10.1001/jama.288.19.2469
  36. Künzler-Heule P, Panfil EM. [Hepatitis C! Experience in diagnosis and medical treatment. A literature review]. Pflege. 2012 Jun;25(3):185–95.
  37. Mayer DK, Nasso SF, Earp JA. Defining cancer survivors, their needs, and perspectives on survivorship health care in the USA. Lancet Oncol. 2017 Jan;18(1):e11–8. https://doi.org/10.1016/S1470-2045(16)30573-3
  38. Frost H, Campbell P, Maxwell M, O’Carroll RE, Dombrowski SU, Williams B, et al. Effectiveness of Motivational Interviewing on adult behaviour change in health and social care settings: A systematic review of reviews. PLoS One. 2018 Oct;13(10):e0204890. https://doi.org/10.1371/journal.pone.0204890
  39. Zimmerman GL, Olsen CG, Bosworth MF. A ‘stages of change’ approach to helping patients change behavior. Am Fam Physician. 2000 Mar;61(5):1409–16.
  40. Neuner-Jehle Stefan. Schmid M, Ueli G. The „Health Coaching“ programme: a new patient centred and visually supported approach for thealth behaviour change in primary care. BMC Fam Pract. 2013;14(100):1471–2296.
  41. Grüninger U, Hösli R, Neuner S, Schmid M. Gesdunheitscoaching- ein Programm für Gesundheitsförderung und Prävention in der Hausarztpraxis vom Kollegium für Hausarztmedizin; (KMH). Schweiz Arzteztg. 2009;90(45):1729–32. https://doi.org/10.4414/saez.2009.14736

Most read articles by the same author(s)

<< < 1 2